The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ATTAINMENT: A phase Ib trial of MDX-124, a first-in-class annexin-A1 targeting antibody, alone and in combination with anti-cancer treatments, in patients with advanced solid tumors.
 
Daniel H. Palmer
Consulting or Advisory Role - AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Eisai; MSD; Roche; Sirtex Medical
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Sirtex Medical
 
Stefan N. Symeonides
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Boxer Capital (Inst); Bristol-Myers Squibb (Inst); Duke Street Bio (Inst); Eisai (Inst); Ellipses Pharma (Inst); Eugit Therapeutics (Inst); EUSA Pharma (Inst); MedAnnex (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Vaccitech (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Eisai (Inst); EUSA Pharma (Inst); Ipsen (Inst)
Research Funding - BiolineRx (Inst); BioNTech (Inst); Boston Pharmaceuticals (Inst); Incyte (Inst); Medannex (Inst); Merck Sharp & Dohme (Inst); Nouscom (Inst); Nucana (Inst); Roche/Genentech (Inst); Sapience Therapeutics (Inst); Scancell (Inst); Sierra Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - BioNTech; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD
 
Fiona C. Dempsey
Employment - Medannex Ltd
Stock and Other Ownership Interests - Medannex Ltd
 
Scott J. Crichton
Employment - Medannex Ltd
Stock and Other Ownership Interests - Medannex Ltd
 
Colin Tennant
Employment - Medannex Ltd
Stock and Other Ownership Interests - Medannex Ltd
 
Christopher B. Wood
Employment - 30Technology Ltd
Leadership - Medannex Ltd, OncoBioPharm Ltd, 30Technology Ltd
Stock and Other Ownership Interests - Medannex Ltd, OncoBioPharm Ltd, 30Technology Ltd
Patents, Royalties, Other Intellectual Property - 30Technology Ltd
 
Ruth Knight
Research Funding - Medannex, MSD, BMS, Roche
 
Silviya Balabanova
Research Funding - Salary has been supported from study research funding (Medannex, MSD, Seagen).
 
Clare Upton
Research Funding - Medannex Ltd
 
Samantha S.P. Low
No Relationships to Disclose
 
Jemma Proudfoot-Jones
No Relationships to Disclose
 
Sohail Rooman Javed
No Relationships to Disclose
 
Aglaia Skolariki
Travel, Accommodations, Expenses - Nucana
 
Sarah Patricia Blagden
Employment - RNA Guardian Ltd (biomarker development)
Leadership - RNA Guardian (Director, Founder)
Stock and Other Ownership Interests - RNA Guardian
Honoraria - Simbec Orion
Consulting or Advisory Role - Theolytics, Oxford Drug Design, Pathios, Terra VC, UCB, Immunocore
Research Funding - Clinical trial funding (as PI or CI) Nucana Plc,, Nurix, Redx, MSD, UCB, Mina therapeutics, BioNTech, Medannex
Patents, Royalties, Other Intellectual Property - Precancer biomarker (RNA Guardian)